» Articles » PMID: 8172890

Active-site Mutations of the Diphtheria Toxin Catalytic Domain: Role of Histidine-21 in Nicotinamide Adenine Dinucleotide Binding and ADP-ribosylation of Elongation Factor 2

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1994 May 3
PMID 8172890
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Diphtheria toxin (DT) has been studied as a model for understanding active-site structure and function in the ADP-ribosyltransferases. Earlier evidence suggested that histidine-21 of DT is important for the ADP-ribosylation of eukaryotic elongation factor 2 (EF-2). We have generated substitutions of this residue by cassette mutagenesis of a synthetic gene encoding the catalytic A fragment (DTA) of DT, and have characterized purified mutant forms of this domain. Changing histidine-21 to alanine, aspartic acid, leucine, glutamine, or arginine diminished ADP-ribosylation activity by 70-fold or greater. In contrast, asparagine proved to be a functionally conservative substitution, which reduced ADP-ribosylation activity by < 3-fold. The asparagine mutant was approximately 50-fold-attenuated in NAD glycohydrolase activity, however. Dissociation constants (Kd) for NAD binding, determined by quenching of the intrinsic protein fluorescence, were 15 microM for wild-type DTA, 160 microM for the asparagine mutant, and greater than 500 microM NAD for the alanine, leucine, glutamine, and arginine mutants. These and previous results support a model of the ADP-ribosylation of EF-2 in which histidine-21 serves primarily a hydrogen-bonding function. We propose that the pi-imidazole nitrogen of His-21 hydrogen-bonds to the nicotinamide carboxamide, orienting the N-glycosidic bond of NAD for attack by the incoming nucleophile in a direct displacement mechanism, and then stabilizing the transition-state intermediate of this reaction.

Citing Articles

A novel predicted ADP-ribosyltransferase-like family conserved in eukaryotic evolution.

Wyzewski Z, Gradowski M, Krysinska M, Dudkiewicz M, Pawlowski K PeerJ. 2021; 9:e11051.

PMID: 33854844 PMC: 7955679. DOI: 10.7717/peerj.11051.


Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity.

Brady P, Goel A, Johnson M Microbiol Mol Biol Rev. 2018; 83(1).

PMID: 30567936 PMC: 6383445. DOI: 10.1128/MMBR.00038-18.


Ligand Selectivity between the ADP-Ribosylating Toxins: An Inverse-Docking Study for Multitarget Drug Discovery.

Saenz-Mendez P, Eriksson M, Eriksson L ACS Omega. 2018; 2(4):1710-1719.

PMID: 30023642 PMC: 6044789. DOI: 10.1021/acsomega.7b00010.


Structural basis for lack of ADP-ribosyltransferase activity in poly(ADP-ribose) polymerase-13/zinc finger antiviral protein.

Karlberg T, Klepsch M, Thorsell A, Andersson C, Linusson A, Schuler H J Biol Chem. 2015; 290(12):7336-44.

PMID: 25635049 PMC: 4367243. DOI: 10.1074/jbc.M114.630160.


Crystal structure of human ADP-ribose transferase ARTD15/PARP16 reveals a novel putative regulatory domain.

Karlberg T, Thorsell A, Kallas A, Schuler H J Biol Chem. 2012; 287(29):24077-81.

PMID: 22661712 PMC: 3397834. DOI: 10.1074/jbc.M112.379289.